REGULARITY OF PSA TESTING AND CANCER RECURRENCE IN PROSTATE CANCER PATIENTS

被引：0
|
作者：
Dupree, James M.
Thakker, Bharat
Casey, Jessica T.
Kim, Dae Y.
Banks, Jessica A.
Loeb, Stacy
Catalona, William J.
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.2054
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1916
引用
收藏
页码：E766 / E766
页数：1
相关论文
共 50 条
  • [21] Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature
    Grisanti, Salvatore
    Antonelli, Alessandro
    Buglione, Michela
    Almici, Camillo
    Foroni, Chiara
    Sodano, Mario
    Triggiani, Luca
    Greco, Diana
    Palumbo, Carlotta
    Marini, Mirella
    Magrini, Stefano M.
    Berruti, Alfredo
    Simeone, Claudio
    ANTICANCER RESEARCH, 2016, 36 (06) : 2975 - 2981
  • [22] Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
    Galego, Pedro
    Silva, Fernando C.
    Pinheiro, Luis Campos
    INTERNATIONAL BRAZ J UROL, 2015, 41 (02): : 353 - 359
  • [23] Complexed PSA and Total PSA in patients with Benign Prostate Hyperplasia and Prostate Cancer
    Tamimi, W.
    Dafterdar, R.
    Mansi, M.
    Alsaad, K.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A111
  • [24] PSA Levels and Mortality in Prostate Cancer Patients
    Jehle, Dietrich von Kuenssberg
    Nguyen, Nam
    Garza, Michael A.
    Kim, Debora K.
    Paul, Krishna K.
    Bilby, Nathaniel J.
    Bogache, William K.
    Chevli, K. Kent
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [25] PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism?
    Albertsen, Peter C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 78 - 81
  • [26] An algorithm with preoperative variables to predict PSA recurrence in prostate cancer patients receiving radical prostatectomy
    Wu, HY
    Sun, L
    Moul, JW
    Wu, HY
    McLeod, DG
    Amling, C
    Lance, R
    Foley, J
    Sexton, W
    Kusuda, L
    Chung, A
    Soderdahl, D
    Donahue, T
    Banez, L
    JOURNAL OF UROLOGY, 2003, 169 (04): : 399 - 399
  • [27] Evaluation of PSA velocity as a selection criterion for FCHPET/CT in patients with biological recurrence of prostate cancer
    Huchet, V.
    Gutman, F.
    Kerrou, K.
    Cussenot, O.
    Haab, F.
    Doublet, J.
    Sebe, P.
    Gattegno, B.
    Montravers, F.
    Thibault, P.
    Talbot, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S123 - S123
  • [28] Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients?
    de la Taille, A
    Rubin, MA
    Buttyan, R
    Olsson, CA
    Bagiella, E
    Burchardt, M
    Wellisch, OM
    Katz, AE
    EUROPEAN UROLOGY, 2000, 38 (01) : 79 - 84
  • [29] Detection of recurrence sites using FCH PET/CT in prostate cancer patients with PSA failure
    Kim, D.
    Lee, W.
    Byun, S.
    Kim, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1167 - S1167
  • [30] Prostate cancer tumor volume does correlate with diagnostic and PSA recurrence
    Moul, JW
    Banez, L
    Sun, L
    Wu, HY
    McLeod, DG
    Sesterhenn, IA
    Mostofi, FK
    Zhao, M
    Chang, J
    JOURNAL OF UROLOGY, 2003, 169 (04): : 441 - 442
12345